Hilde Morris has recently been appointed to replace our outgoing clinical director Dr. Astrid Hilde Myrset, who will continue in a consultancy in the short term to ensure a smooth transition of the role. Hilde Morris will take over the Cystic Fibrosis clinical development program at AlgiPharma. She is a veterinarian by training, and has previously held leading positions within clinical research in Nycomed-Imaging-Amersham-GE Healthcare, as well as in Photocure ASA, where she was VP of R&D until 2006. From 2007 to 2017. Hilde has worked as an independent consultant within the fields of clinical research regulatory affairs. She has had responsibility for coordinating multiple international clinical trial programs from phase I – IV for a wide range of pharmaceuticals in the US, EU and Australia, and has over 25 years’ experience interacting with international regulatory authorities.
http://algipharma.com/wp-content/uploads/2016/03/algipharma-logo-skisse-340x156.png 0 0 Philip Rye http://algipharma.com/wp-content/uploads/2016/03/algipharma-logo-skisse-340x156.png Philip Rye2017-11-09 08:03:192023-08-09 17:05:12Hilde Morris joins AlgiPharma